Table 2.
Correlation coefficients (Pearson's) and their significance (P; Student's unpaired t-test) are shown for the expression of mTOR, ULK1, p21, caspase 3, and TNFα genes in OA patients and healthy subjects in relation to each other and clinical traits.
| Set 1 patients | mTOR | ULK1 | Caspase 3 | TNFα |
|---|---|---|---|---|
|
“Low mTOR” subset OA patients (n = 15) |
||||
| Caspase 3 | 0.645 P = 0.009 |
|||
| Pain on walking | −0.568 P = 0.02 |
|||
| Pain on standing | −0.701 P = 0.004 |
|||
| Total physical function | −0.674 P = 0.007 |
|||
| Total WOMAC |
−0.633 P = 0.007 |
|||
| BMD L1–L4 |
0.544 P = 0.03 |
|||
| BMD total femur | 0.580 P = 0.02 |
|||
|
| ||||
| “High mTOR” subset OA patients (n = 32) |
||||
| mTOR | 0.369 P = 0.03 |
0.408 P = 0.02 |
0.691 P < 0.001 |
|
| P21 | 0.360 P = 0.04 |
0.683 P < 0.001 |
0.354 P = 0.04 |
|
| Caspase 3 | 0.502 P = 0.003 |
|||
| BMI |
0.432 P = 0.01 |
|||
| BMD L1–L4 |
0.454 P = 0.009 |
|||
| BMD femoral neck | 0.439 P = 0.01 |
|||
| ESR | 0.442 P = 0.01 |
|||
|
| ||||
| End-stage OA patients (n = 14) |
||||
| mTOR | 0.549 P = 0.04 |
|||
| ULK1 | 0.813 P < 0.001 |
|||
| P21 | 0.770 P = 0.001 |
0.756 P = 0.02 |
||
|
| ||||
| Healthy subjects | ||||
| TNFα | −0.560 P = 0.03 |
0.639 P = 0.01 |
0.556 P = 0.03 |
|
Only significant data are presented. ESR: erythrocyte sedimentation rate; WOMAC: Western Ontario and McMaster Universities osteoarthritis index; BMD: bone mineral density; BMI: body mass index.